Clinical Trial Update: Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms [Phase 3]

View source ↗

Summary

A Phase 3 study is underway to test adjunctive Seltorexant in adults with major depressive disorder and insomnia symptoms. The sponsor is Janssen Research & Dev…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Seltorexant (seltorexant)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Depressive Disorder, Major | Phase 3 | Status: RECRUITING